Lars P. van der Heide

3.0k total citations · 1 hit paper
25 papers, 2.4k citations indexed

About

Lars P. van der Heide is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Lars P. van der Heide has authored 25 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Lars P. van der Heide's work include Nuclear Receptors and Signaling (8 papers), FOXO transcription factor regulation (6 papers) and Pluripotent Stem Cells Research (4 papers). Lars P. van der Heide is often cited by papers focused on Nuclear Receptors and Signaling (8 papers), FOXO transcription factor regulation (6 papers) and Pluripotent Stem Cells Research (4 papers). Lars P. van der Heide collaborates with scholars based in Netherlands, Sweden and Switzerland. Lars P. van der Heide's co-authors include Marten P. Smidt, Marco F.M. Hoekman, Geert M. J. Ramakers, Amer Kamal, Willem Hendrik Gispen, Geert Jan Biessels, Ronald L. A. W. Bleys, J. Peter H. Burbach, Frank M. J. Jacobs and Patrick J. Wijchers and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and PLoS ONE.

In The Last Decade

Lars P. van der Heide

24 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation

2004 567 citations Lars P. van der Heide, Marco F.M. Hoekman et al. Biochemical Journal profile →

Peers

Countries citing papers authored by Lars P. van der Heide

Since Specialization

Citations

This map shows the geographic impact of Lars P. van der Heide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars P. van der Heide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars P. van der Heide more than expected).

Fields of papers citing papers by Lars P. van der Heide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars P. van der Heide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars P. van der Heide. The network helps show where Lars P. van der Heide may publish in the future.

Co-authorship network of co-authors of Lars P. van der Heide

This figure shows the co-authorship network connecting the top 25 collaborators of Lars P. van der Heide. A scholar is included among the top collaborators of Lars P. van der Heide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars P. van der Heide. Lars P. van der Heide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The absence of Pitx3 results in postnatal loss of dopamine neurons and is associated with an increase in the pro-apoptotic Bcl2 factor Noxa and cleaved caspase 3 2025 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Lars von Oerthel, Marten P. Smidt, Lars P. van der Heide	2
2	Boosting endogenous dopamine production: a novel therapeutic approach for Parkinson’s disease 2024 ·Trends in Molecular Medicine ·(unknown), Marten P. Smidt, Lars P. van der Heide	3
3	Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits 2024 ·Cell & Bioscience ·(unknown), (unknown), (unknown), Marten P. Smidt, Lars P. van der Heide	0
4	Tyrosine hydroxylase phosphorylation is under the control of serine 40 2023 ·Journal of Neurochemistry ·(unknown), (unknown), (unknown), Marten P. Smidt, Lars P. van der Heide	6
5	MCL1 as a Therapeutic Target in Parkinson's Disease? 2019 ·Trends in Molecular Medicine ·(unknown), (unknown), Marten P. Smidt, Lars P. van der Heide	9
6	Transforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output 2019 ·Journal of Biological Chemistry ·Constantinos Kolliopoulos, Erna Raja, (unknown), Paraskevi Heldin, Carl‐Henrik Heldin, Aristidis Moustakas, Lars P. van der Heide	27
7	Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1 2018 ·Cell Death Discovery ·(unknown), (unknown), (unknown), (unknown), Lars von Oerthel, Marten P. Smidt, Lars P. van der Heide	18
8	FoxK2 is Required for Cellular Proliferation and Survival 2014 ·Journal of Cellular Physiology ·Lars P. van der Heide, Patrick J. Wijchers, Lars von Oerthel, J. Peter H. Burbach, Marco F.M. Hoekman, Marten P. Smidt	27
9	Fine-Tuning of Smad Protein Function by Poly(ADP-Ribose) Polymerases and Poly(ADP-Ribose) Glycohydrolase during Transforming Growth Factor β Signaling 2014 ·PLoS ONE ·Markus Dahl, (unknown), Peter Lönn, Panagiotis Papoutsoglou, Agata Zieba, Michael Vanlandewijck, Lars P. van der Heide, Yukihide Watanabe, Ola Söderberg, Michael O. Hottiger, Carl‐Henrik Heldin, Aristidis Moustakas	22
10	The BCL2 code to dopaminergic development and Parkinson's disease 2013 ·Trends in Molecular Medicine ·Lars P. van der Heide, Marten P. Smidt	21
11	Lmx1a Encodes a Rostral Set of Mesodiencephalic Dopaminergic Neurons Marked by the Wnt/B-Catenin Signaling Activator R-spondin 2 2013 ·PLoS ONE ·(unknown), Lars von Oerthel, Lars P. van der Heide, (unknown), Jesse V. Veenvliet, (unknown), Yong-Ri Jin, Jeong Kyo Yoon, Annemarie J. A. van der Linden, Frank C. P. Holstege, Marian J.A. Groot Koerkamp, Marten P. Smidt	34
12	TGFβ Activates Mitogen- and Stress-activated Protein Kinase-1 (MSK1) to Attenuate Cell Death 2010 ·Journal of Biological Chemistry ·Lars P. van der Heide, Maarten van Dinther, Aristidis Moustakas, Peter ten Dijke	25
13	PARP-1 Attenuates Smad-Mediated Transcription 2010 ·Molecular Cell ·Peter Lönn, Lars P. van der Heide, Markus Dahl, Ulf Hellman, Carl‐Henrik Heldin, Aristidis Moustakas	115
14	Insulin signaling in the central nervous system: Learning to survive 2006 ·Progress in Neurobiology ·Lars P. van der Heide, Geert M. J. Ramakers, Marten P. Smidt	354
15	Insulin modulates hippocampal activity‐dependent synaptic plasticity in a N‐methyl‐d‐aspartate receptor and phosphatidyl‐inositol‐3‐kinase‐dependent manner 2005 ·Journal of Neurochemistry ·Lars P. van der Heide, Amer Kamal, Alain Artola, Willem Hendrik Gispen, Geert M. J. Ramakers	211
16	Regulation of FoxO activity by CBP/p300-mediated acetylation 2004 ·Trends in Biochemical Sciences ·Lars P. van der Heide, Marten P. Smidt	149
17	The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation breakdown → 2004 ·Biochemical Journal ·Lars P. van der Heide, Marco F.M. Hoekman, Marten P. Smidt	567
18	Insulin inhibits extracellular regulated kinase 1/2 phosphorylation in a phosphatidylinositol 3‐kinase (PI3) kinase‐dependent manner in Neuro2a cells 2003 ·Journal of Neurochemistry ·Lars P. van der Heide, Marco F.M. Hoekman, Geert Jan Biessels, W.H. Gispen	32
19	FoxO6, a Novel Member of the FoxO Class of Transcription Factors with Distinct Shuttling Dynamics 2003 ·Journal of Biological Chemistry ·Frank M. J. Jacobs, Lars P. van der Heide, Patrick J. Wijchers, J. Peter H. Burbach, Marco F.M. Hoekman, Marten P. Smidt	277
20	Ageing and diabetes: implications for brain function 2002 ·European Journal of Pharmacology ·Geert Jan Biessels, Lars P. van der Heide, Amer Kamal, Ronald L. A. W. Bleys, Willem Hendrik Gispen	372

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact